US Patent 7524492 Insulin related transcription factor and uses thereof
Patent 7524492 was granted and assigned to Joslin Diabetes Center (company) on April, 2009 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7524492 Insulin related transcription factor and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
